Scientific Advisors
Horizon's scientific advisors are leading industry experts and key opinion leaders in the areas of gastroenterology, pain management, and clinical trial design.
Loren Laine, M.D.
Professor of Medicine Gatrointestinal and Liver Disease, University of Southern California
Loren Laine is a Professor of Medicine at the Keck School of Medicine of the University of Southern California in Los Angeles. He is also Chief of the Gastroenterology Section at the Los Angeles County + U.S.C. Medical Center. Dr Laine is immediate past chair of the American Gastroenterological Association (AGA) Council and a past chair of the AGA Clinical Practice Section. He also has been a member of the American Board of Internal Medicine and the FDA Gastrointestinal Advisory Board. Dr. Laine has served as an associate editor of the Yamada Textbook of Gastroenterology and the journals Gastroenterology and Gastrointestinal Endoscopy. Dr Laine is currently on the editorial boards of the American Journal of Medicine, Alimentary Pharmacology and Therapeutics, Clinical Gastroenterology and Hepatology, and Evidence-Based Gastroenterology.
Michael E. Weinblatt, MD
Co-director of Clinical Rheumatology at the Brigham and Women's Hospital and the John R. and Eileen K. Professor of Medicine at Harvard Medical School, Boston, Massachusetts
Dr. Weinblatt's major research interest is in therapeutics for rheumatoid arthritis. His work on the development of methotrexate therapy for rheumatoid arthritis garnered him the Carol Nachman Prize for Rheumatology and the Arthritis Foundation Virginia P. Engalitcheff Award for Impact on Quality of Life. Author of The Arthritis Action Program: An Integrated Plan of Traditional and Complementary Therapies he is also the co-editor of Treatment of Rheumatic Diseases and an editor of the textbook Rheumatology 3rd and 4th editions and currently sits on multiple editorial boards including Journal of Rheumatology. In 2001 he served as President of the American College of Rheumatology.
Michael H. Schiff, MD
Clinical Professor of Medicine, Rheumatology Division, University of Colorado School of Medicine, Denver, Colorado
Dr. Schiff is board certified in Internal Medicine and Rheumatology. He has received a number of Outstanding Clinical Facility awards from the University Of Colorado School Of Medicine, including the Academic Publications Award and the Research Project Award. He recently was awarded the University of Colorado Career Achievement Award 2006. He has been principle investigator for over 200 research projects. He has published 42 peer reviewed journal articles and 143 scientific abstracts. He is a fellow of the American College of Rheumatology, as well as a member of a number of regional and national medical societies. In addition, Dr. Schiff has served as a Board Member of the American College of Rheumatology’s Research Educations Foundation. He was Vice President from 2001-2002. He served 2 terms as president of the Colorado Society of Internal Medicine. His primary interest has been in the use of DMARDS and Biologics for management of Rheumatoid Arthritis.
Mark C. Genovese, MD
Co-Chief of the Division of Immunology and Rheumatology and Associate Professor at Stanford University Medical Center
Dr. Genovese received his medical degree from the Johns Hopkins University School of Medicine. He completed an internship, residency, and chief residency in the Department of Medicine at Stanford University. He is the clinic chief and directs the Immunology and Rheumatology fellowship program. He has designed and participated in many investigator-initiated studies and multi-center trials investigating novel therapies and therapeutic strategies for the treatment of autoimmune disease and arthritis. Dr. Genovese is also the Director of the Center for Clinical Investigation in the Stanford Department of Medicine. Dr. Genovese has served as an editor for the textbook Primary Care Rheumatology and as an associate editor for Kelley’s Essentials of Internal Medicine. He is an editor on the 7th edition of Kelley’s Textbook of Rheumatology. Dr. Genovese is an ad hoc reviewer for numerous medical journals, a board member of the Stanford General Clinical Research Center, and he was the recipient of a Center of Immunology at Stanford clinical scholars’ award.
Thomas Fleming, Ph.D.
Professor of Biostatistics, University of Washington
Thomas Fleming, PhD is Professor of the Department of Biostatistics in the School of Public Health and Community Medicine at the University of Washington. He is also a Member at the FHCRC, and is a Special Government Employee at FDA. He is Director of both the Biostatistics/Epidemiology Core in the Center for AIDS Research at UW and the Statistical Center for the HIV/AIDS Prevention Trials Network sponsored by NIAID. His major research interests are in survival analysis, sequential analysis, and the science of the design, conduct and statistical analysis of clinical trials. He has received the Outstanding Teaching Award from the School of Public Health and the FDA Commissioner's Special Citation Award for Extraordinary Contributions to the Agency.
James Scheiman, M.D.
Professor of Medicine Gastroenterology, University of Michigan
James Scheiman is Professor of Medicine and Gastroenterology at the University of Michigan Medical School. He is a native of the Detroit area and received his undergraduate, graduate, and post-graduate training at the University of Michigan. He has been a member of the faculty since 1987. Dr Scheiman's interest and research is focused on the pathogenesis and management of both Helicobacter pylori and NSAID-associated peptic ulcer disease. Dr Scheiman is also Director of the Endoscopic Ultrasound program at the University of Michigan Health System. He is a fellow of the American College of Physicians, the American Gastroenterological Association, American Society of Gastrointestinal Endoscopy and the American College of Gastroenterology. He is additionally on the editorial board of the Journal of Clinical Gastroenterology and the Journal of Musculoskeletal Medicin. Dr Scheiman has authored over 160 publications and book chapters. He is a frequent speaker at national and international meetings, discussing his work in NSAID therapy and peptic ulcer disease, dyspepsia, pharmacoeconomics, and endosocpic ultrasound.
Philip O. Katz, M.D.
Clinical Professor of Medicine at Thomas Jefferson University and Chairman of the Division of Gastroenterology at Albert Einstein Medical Center in Philadelphia, Pennsylvania
Dr. Katz received his medical degree from the Bowman Gray School of Medicine at Wake Forest University in Winston-Salem, North Carolina. He served his residency and chief residency in internal medicine, followed by a fellowship in gastroenterology at the Bowman Gray School of Medicine. He completed a faculty development fellowship at Johns Hopkins University in Baltimore, Maryland. He is board certified in internal medicine and gastroenterology. Dr. Katz is currently Treasurer of the American College of Gastroenterology and is a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. A recognized national authority on esophageal disease, Dr. Katz’s research interests include all aspects of gastroesophageal reflux disease, including nocturnal recovery of gastric acid secretion during proton pump inhibitor therapy and esophageal pain perception. Dr. Katz is a practicing clinician with active teaching and editorial positions. In addition to lecturing on many gastroenterology-related topics, Dr. Katz is Associate Editor for Reviews in Gastrointestinal Disorders (Med Reviews) and an editorial reviewer for Annals of Internal Medicine, American Journal of Gastroenterology, Gastroenterology, and Digestive Diseases and Sciences. He has contributed to the publication of over 120 peer-reviewed papers, as well as numerous abstracts, books, book chapters, and monographs.